ClinicalTrials.Veeva

Menu

Postoperative Pain Control by Use of Many Drugs in Small Doses Intrathecally

S

Sohag University

Status and phase

Unknown
Phase 2

Conditions

Post Operative Pain

Treatments

Drug: Morphine Sulfate
Drug: Bupivacaine
Drug: dexamethasone, morphine, midazolam

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Cesarean section is one of the painful operations that require adequate postoperative analgesia. Patients are divided into two groups: Multimodal (DMM) group ( 30 patients): patients will receive spinal anesthesia with 10-12.5 mg bupivacaine and 1 ml containing 2 mg dexamethasone, 50 µg morphine, and 500 µg midazolam.

Morphine (M) group (30 patients): patients will receive spinal anesthesia with 10-12.5 mg bupivacaine and 1 ml containing 200 µg morphine

Enrollment

60 estimated patients

Sex

Female

Ages

20 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA I-II
  • Age 20-40 years.
  • Pregnant women with living fetus.
  • Body mass index 20- 35 kg/m2.

Exclusion criteria

  • Patient refusal.
  • Age < 20 or > 40 years
  • Body mass index < 20 or > 35.
  • Contraindication to spinal anesthesia (severe mitral or aortic stenosis, coagulopathy, Systemic or local infection, increased intracranial pressure and hypovolemia).
  • Placental abnormalities: placental abruption, placenta previa or accrete.
  • Allergy to drugs used in the study.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 2 patient groups

Morphine
Active Comparator group
Description:
Patients will receive 10-12.5 mg bupivacaine and 1 ml containing 200 µg of morphine intrathecally.
Treatment:
Drug: Bupivacaine
Drug: Morphine Sulfate
Multimodal
Active Comparator group
Description:
Patients will receive 10-12.5 mg bupivacaine and 1 ml containing 2 mg dexamethasone, 50 µg morphine, and 500 µg midazolam intrathecally
Treatment:
Drug: Bupivacaine
Drug: dexamethasone, morphine, midazolam

Trial contacts and locations

1

Loading...

Central trial contact

Fouad Soliman

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems